IMMUCELL CORP /DE/ Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Immucell Corp /De/ quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2018 to Q4 2023.
  • Immucell Corp /De/ Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $4.03M, a 48.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $4.03M +$1.33M +48.9% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $2.71M +$2.63M +3369% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $78.1K -$350K -81.8% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $428K -$1.11M -72.2% Dec 31, 2020 10-K 2022-03-30
Q4 2019 $1.54M +$296K +23.9% Dec 31, 2019 10-K 2021-03-30
Q4 2018 $1.24M Dec 31, 2018 10-K 2020-03-27
Q3 2018 $879K Sep 30, 2018 10-Q 2018-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.